| Eric J Graham, MD | |
|
15476 Dedeaux Rd, Gulfport, MS 39503-2637 | |
| (228) 230-2663 | |
| (228) 679-3038 |
| Full Name | Eric J Graham |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 28 Years |
| Location | 15476 Dedeaux Rd, Gulfport, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558462218 | NPI | - | NPPES |
| 00126157 | Medicaid | MS | |
| P00285790 | Other | MS | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 17733 (Mississippi) | Primary |
| 174400000X | Specialist | 17733 (Mississippi) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Singing River Health System | Pascagoula, MS | Hospital |
| Garden Park Medical Center | Gulfport, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bienville Orthopaedic Specialists, Llc | 0547155178 | 47 |
| Oal Care Of Al, Llc | 1254668031 | 10 |
News Archive
Covance Inc., a leading provider of drug development services, announced today that it entered into a biomarker alliance and services agreement with Rules-Based Medicine, Inc. (RBM), a leading provider of multiplexed protein biomarker testing to the pharmaceutical industry.
The Cell Therapy Catapult has published its annual analysis of the UK preclinical and clinical research landscapes with the release of its UK Clinical and Pre-Clinical Trials Databases. These show a 24% rise in the number of clinical trials and an increase of 22% in the number of pre-clinical projects. Sector growth came in the key areas of oncology, neurology, ophthalmology and cardiovascular.
A newly improved internet research tool is helping cancer researchers and physicians make sense out of a deluge of genetic data from nearly 100,000 patients and more than 50,000 mice.
The New York Times: "A West Texas jury took but an hour Thursday to acquit a nurse who had been charged with a felony after alerting the state medical board that a doctor at her hospital was practicing unsafe medicine. The uncommon prosecution had ignited deep concern among health care workers and advocates for whistle-blowers about a potential chilling effect on the reporting of malpractice.
Compugen Ltd. announced today the development and validation of its Intracellular Drug Delivery (IDD) discovery platform for identification of cell penetrating peptides. Compugen also announced that as part of the validation process for the new platform, more than twenty novel peptides, predicted and selected in silico, demonstrated the predicted cell penetrating properties in initial experimental validation studies.
› Verified 5 days ago
| Entity Name | Bienville Orthopaedic Specialists, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689605834 PECOS PAC ID: 0547155178 Enrollment ID: O20040220000834 |
News Archive
Covance Inc., a leading provider of drug development services, announced today that it entered into a biomarker alliance and services agreement with Rules-Based Medicine, Inc. (RBM), a leading provider of multiplexed protein biomarker testing to the pharmaceutical industry.
The Cell Therapy Catapult has published its annual analysis of the UK preclinical and clinical research landscapes with the release of its UK Clinical and Pre-Clinical Trials Databases. These show a 24% rise in the number of clinical trials and an increase of 22% in the number of pre-clinical projects. Sector growth came in the key areas of oncology, neurology, ophthalmology and cardiovascular.
A newly improved internet research tool is helping cancer researchers and physicians make sense out of a deluge of genetic data from nearly 100,000 patients and more than 50,000 mice.
The New York Times: "A West Texas jury took but an hour Thursday to acquit a nurse who had been charged with a felony after alerting the state medical board that a doctor at her hospital was practicing unsafe medicine. The uncommon prosecution had ignited deep concern among health care workers and advocates for whistle-blowers about a potential chilling effect on the reporting of malpractice.
Compugen Ltd. announced today the development and validation of its Intracellular Drug Delivery (IDD) discovery platform for identification of cell penetrating peptides. Compugen also announced that as part of the validation process for the new platform, more than twenty novel peptides, predicted and selected in silico, demonstrated the predicted cell penetrating properties in initial experimental validation studies.
› Verified 5 days ago
| Entity Name | Oal Care Of Al, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720540693 PECOS PAC ID: 1254668031 Enrollment ID: O20210422000100 |
News Archive
Covance Inc., a leading provider of drug development services, announced today that it entered into a biomarker alliance and services agreement with Rules-Based Medicine, Inc. (RBM), a leading provider of multiplexed protein biomarker testing to the pharmaceutical industry.
The Cell Therapy Catapult has published its annual analysis of the UK preclinical and clinical research landscapes with the release of its UK Clinical and Pre-Clinical Trials Databases. These show a 24% rise in the number of clinical trials and an increase of 22% in the number of pre-clinical projects. Sector growth came in the key areas of oncology, neurology, ophthalmology and cardiovascular.
A newly improved internet research tool is helping cancer researchers and physicians make sense out of a deluge of genetic data from nearly 100,000 patients and more than 50,000 mice.
The New York Times: "A West Texas jury took but an hour Thursday to acquit a nurse who had been charged with a felony after alerting the state medical board that a doctor at her hospital was practicing unsafe medicine. The uncommon prosecution had ignited deep concern among health care workers and advocates for whistle-blowers about a potential chilling effect on the reporting of malpractice.
Compugen Ltd. announced today the development and validation of its Intracellular Drug Delivery (IDD) discovery platform for identification of cell penetrating peptides. Compugen also announced that as part of the validation process for the new platform, more than twenty novel peptides, predicted and selected in silico, demonstrated the predicted cell penetrating properties in initial experimental validation studies.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric J Graham, MD 6300 E Lake Blvd, Suite 301, Vancleave, MS 39565-6770 Ph: (228) 230-2663 | Eric J Graham, MD 15476 Dedeaux Rd, Gulfport, MS 39503-2637 Ph: (228) 230-2663 |
News Archive
Covance Inc., a leading provider of drug development services, announced today that it entered into a biomarker alliance and services agreement with Rules-Based Medicine, Inc. (RBM), a leading provider of multiplexed protein biomarker testing to the pharmaceutical industry.
The Cell Therapy Catapult has published its annual analysis of the UK preclinical and clinical research landscapes with the release of its UK Clinical and Pre-Clinical Trials Databases. These show a 24% rise in the number of clinical trials and an increase of 22% in the number of pre-clinical projects. Sector growth came in the key areas of oncology, neurology, ophthalmology and cardiovascular.
A newly improved internet research tool is helping cancer researchers and physicians make sense out of a deluge of genetic data from nearly 100,000 patients and more than 50,000 mice.
The New York Times: "A West Texas jury took but an hour Thursday to acquit a nurse who had been charged with a felony after alerting the state medical board that a doctor at her hospital was practicing unsafe medicine. The uncommon prosecution had ignited deep concern among health care workers and advocates for whistle-blowers about a potential chilling effect on the reporting of malpractice.
Compugen Ltd. announced today the development and validation of its Intracellular Drug Delivery (IDD) discovery platform for identification of cell penetrating peptides. Compugen also announced that as part of the validation process for the new platform, more than twenty novel peptides, predicted and selected in silico, demonstrated the predicted cell penetrating properties in initial experimental validation studies.
› Verified 5 days ago
Philip D Myers, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 15190 Community Rd Ste 120, Gulfport, MS 39503 Phone: 228-205-6825 Fax: 228-831-8782 | |
Dr. Timothy D Jackson, MD, SA-C Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4500 13th St, Gulfport, MS 39501 Phone: 228-304-9436 | |
Dr. William Lewis Seidensticker, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2 Bayou Pl, Gulfport, MS 39503 Phone: 222-889-6708 | |
Dr. Eric Jude Letonoff, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 15190 Community Rd Ste 120, Gulfport, MS 39503 Phone: 228-205-6825 Fax: 228-831-8782 | |
Dr. Inez M Kelleher, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1340 Broad Ave, Ste 450, Gulfport, MS 39503 Phone: 228-867-5012 Fax: 228-867-5262 | |
Joseph Tyler Cox, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 15476 Dedeaux Rd, Gulfport, MS 39503 Phone: 228-230-2663 Fax: 228-546-3257 |